Dr. Chang's published reports and presentations on Dendritic Cell Cancer Therapy

2004

Cancer therapy with unloaded monocyte-derived dendritic cells inpatients with inoperable pancreatic and gallbladder cancer. American Society of Clinical Oncology Annual Meeting Proceedings, 24:180, 2004.

2005

Cancer therapy with immature monocyte-derived dendritic cells in patients with advanced breast cancer Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005: 2528.

2006

Cancer therapy with tumor cell lysate pulsed monocyte-derived dendritic cells in patients with metastastic colon cancer: Improvement by danger signals. In: Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 2563.

2007

Dendritic Cell Therapy in Glioblastoma Multiforme. In: Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007:3065.

2008

Immunotherapy with dendritic cells primed with an allogenic melanoma cell line in advanced metastatic melanoma. Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition. Vol 26, No 15S (May 20 Supplement), 2008: 20026.

2009

Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. J Clin Oncol 27:15s, 2009 (suppl; abstr 3028).